Platelets and heart failure

被引：104

作者：

Chung, Irene ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England

来源：

EUROPEAN HEART JOURNAL | 2006年 / 27卷 / 22期

关键词：

platelet activation; heart failure; CD40L; P-selectin; antiplatelet therapy;

D O I：

10.1093/eurheartj/ehl305

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure is associated with increased risk of venous thromboembolism, stroke, and sudden death. Platelet abnormalities have been well described in heart failure but the significance of platelets in contributing to the thromboembolic complications of heart failure remains uncertain. Furthermore, the role of antiplatelet agents in heart failure remains unclear. This review will focus on platelet activation and the role of platelet dysfunction in heart failure, with particular regard to pathophysiology and outcome. The effects of heart failure therapeutics on platelet function and antiplatelet therapy in heart failure will also be discussed.

引用

收藏

页码：2623 / 2631

页数：9

相关论文

共 72 条

[21] Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure - A dose-related adverse effect of aspirin [J].

Guazzi, M ;

Brambilla, R ;

Reina, G ;

Tumminello, G ;

Guazzi, MD .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1574-1579

[22]

GUPTA RK, 1991, J CARDIOVASC PHARM, V17, P13, DOI 10.1097/00005344-199101000-00003

[23] Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes? [J].

Gurbel, PA ;

Gattis, WA ;

Fuzaylov, SF ;

Gaulden, L ;

Hasselblad, V ;

Serebruany, VL ;

O'Connor, CM .

AMERICAN HEART JOURNAL, 2002, 143 (06) :1068-1075

[24] PLATELET-FUNCTION, THROMBIN AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH HEART-FAILURE [J].

JAFRI, SM ;

OZAWA, T ;

MAMMEN, E ;

LEVINE, TB ;

JOHNSON, C ;

GOLDSTEIN, S .

EUROPEAN HEART JOURNAL, 1993, 14 (02) :205-212

[25] Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release [J].

Kalinowski, L ;

Matys, T ;

Chabielska, E ;

Buczko, W ;

Malinski, T .

HYPERTENSION, 2002, 40 (04) :521-527

[26] Blockade of NF-κB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II [J].

Kawano, S ;

Kubota, T ;

Monden, Y ;

Kawamura, N ;

Tsutsui, H ;

Takeshita, A ;

Sunagawa, K .

CARDIOVASCULAR RESEARCH, 2005, 67 (04) :689-698

[27] Fosinopril reduces ADP-Induced platelet aggregation in hypertensive patients [J].

Keidar, S ;

Oiknine, J ;

Leiba, A ;

Shapira, C ;

Leiba, M ;

Aviram, M .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (02) :183-186

[28] Effects of coadministration of Aspirin or Clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors [J].

Kindsvater, S ;

Leclerc, K ;

Ward, J .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (11) :1350-1352

[29] Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function - Possible importance for the treatment of unstable angina [J].

Knight, CJ ;

Panesar, M ;

Wilson, DJ ;

Chronos, NAF ;

Patel, D ;

Fox, K ;

Goodall, AH .

CIRCULATION, 1997, 95 (01) :125-132

[30] DIFFERENT EFFECTS OF FUROSEMIDE ON ALPHA-ADRENOCEPTORS AND ON PLATELET-AGGREGATION IN MAN [J].

KRIBBEN, A ;

FRITSCHKA, E ;

SIBOLD, M ;

FASSBENDER, M ;

ROTHSCHILD, M ;

DISTLER, A ;

PHILIPP, T .

KLINISCHE WOCHENSCHRIFT, 1988, 66 (14) :624-627

← 1 2 3 4 5 6 7 8 →